A detailed history of Virginia Retirement Systems Et Al transactions in Immunome Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 58,400 shares of IMNM stock, worth $977,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,400
Previous 46,000 26.96%
Holding current value
$977,615
Previous $427,000 58.31%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$8.4 - $11.59 $104,160 - $143,716
12,400 Added 26.96%
58,400 $676,000
Q2 2025

Jul 29, 2025

BUY
$5.56 - $9.79 $145,116 - $255,518
26,100 Added 131.16%
46,000 $427,000
Q1 2025

Jul 16, 2025

BUY
$6.73 - $11.83 $133,927 - $235,417
19,900 New
19,900 $133,000

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $203M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.